Atara Biotherapeutics, Inc., a commercially available T-cell immunotherapy company, develops treatments for cancer patients, autoimmune and viral diseases in the United States. The company is headquartered in South San Francisco, California. Show more
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, UNITED STATES, 91320, Thousand Oaks, CA, 91320, USA
Market Cap
97.97M
52 Wk Range
$3.92 - $19.14
Previous Close
$9.53
Open
$9.45
Volume
135,655
Day Range
$9.25 - $9.95
Enterprise Value
95.67M
Cash
3.221M
Avg Qtr Burn
-3.338M
Insider Ownership
15.14%
Institutional Own.
57.67%
Qtr Updated
06/30/26
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Tabelecleucel (tab-cel® or Ebvallo™) Details Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) | BLA FDA meeting | |
ATA188 Details Multiple sclerosis, Epstein-Barr virus | Failed Discontinued | |
ATA3219 Details Non-Hodgkin lymphoma, Blood cancer, Cancer | Failed Discontinued | |
ATA3219 Details Systemic lupus erythematosus, Lupus nephritis, Autoimmune disease | Failed Discontinued |
